> Investors > 2016 News Releases

2016 News Releases

Webcast ImageWebcast
Q2 Fiscal 2016 Aceto Earnings Conference Call (Replay)
02/05/16 at 9:00 a.m. ET
Q2 Fiscal 2016 Aceto Earnings Conference Call
Friday, February 5, 2016 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
Category
Year   
DateTitle 
02/04/16ACETO Reports Fiscal 2016 Second Quarter Results
PORT WASHINGTON, N.Y., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2016 ended December 31, 2015. Second Quarter Fiscal 2016 versus Second Quarter Fiscal 2015 Net sales of $131.7 million versus $123.8 million, a 6.4% increase Gross profit of $35... 
Printer Friendly Version
02/04/16ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share.  This quarterly cash dividend will be distributed on March 25, 2016 to shareholders of record as of March 11, 2016. ABOUT ACETO ACETO Corp... 
Printer Friendly Version
01/27/16ACETO Corporation Schedules Second Quarter & Fiscal 2016 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Jan. 27, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2016 ended December 31, 2015 after the stock market close on Thursday, February 4, 2016. Management will host a conference call to discuss the operating and financial resu... 
Printer Friendly Version
01/25/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Zolmitriptan Tablets
PORT WASHINGTON, N.Y., Jan. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Zolmitriptan Tablets, 2.5mg and 5mg, an FDA approved generic version of IPR Pharmaceuticals, Inc.’s Zomig®.   According to IMS Health data, U.... 
Printer Friendly Version

top